Brainstorm Health Daily: February 15, 2017

Merck is the latest company to weather bad news in the Alzheimer’s drug race, halting a late-stage trial yesterday in an experimental amyloid-targeting candidate called verubecestat after a data monitoring committee said there was “virtually no chance of finding a positive clinical effect,” Reuters reported. Merck shares got hammered in after-hours trading Tuesday evening and during the early morning rush, but had fully recovered by mid-morning. (The stock is actually at a 52-week high now.) Who knows? Maybe savvy traders expected the rotten news. After all, Merck simply joins a…

Read More

Nokia Android Phones Expected as HMD Global Sends Invites for February 26 Event

HMD Global has started sending media invites for an event on February 26 where it is expected to reveal more Nokia-branded Android smartphones. HMD Global, the company that owns rights to the Nokia brand, had earlier teased more smartphone launches at the sidelines of Mobile World Congress (MWC) 2017 event next month. According to the official invite, the Nokia event will take place in Barcelona on February 26, and it will kick off at 4:30pm local time (9pm IST). The official invite says, “We invite you to join us at…

Read More